TuHURA Biosciences, Inc. HURA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $0— | $0— | $0— | $0— | $0— | ||
| $5.23M-13.6% | $6.06M+21.9% | $4.97M+0.8% | $4.93M+7.5% | $4.58M+15.2% | ||
| $2.3M— | —— | $1.76M-64.4% | $4.95M+145% | $2.02M+57.8% | ||
| $23.47K+4.1% | $22.54K+5.9% | $21.29K+59.2% | $13.37K-4.9% | $14.06K-20.3% | ||
| —— | —— | —— | —— | $419.04K+281% | ||
| $7.53M-7.9% | $8.17M+21.5% | $6.73M-31.9% | $9.88M+40.7% | $7.02M+23.2% | ||
| $7.53M-7.9% | $8.17M+21.5% | $6.73M-31.9% | $9.88M+40.7% | $7.02M+23.2% | ||
| $27.97K-95.4% | $608.75K+3,582% | $16.53K— | —— | —— | ||
| $21.28K+3,393% | $609-90.0% | $6.06K-79.4% | $29.47K-70.6% | $100.1K-39.0% | ||
| -$6.7K-100% | $1.41M+479% | -$372.85K-206% | $352.12K-0.2% | $352.65K-90.9% | ||
| -$7.54M-11.5% | -$6.76M+4.8% | -$7.1M+25.4% | -$9.52M-42.9% | -$6.66M-11.2% | ||
| $2.09K0.0% | $2.09K0.0% | $2.09K0.0% | $2.09K0.0% | $2.09K— | ||
| -$0.130.0% | -$0.13+7.1% | -$0.14+33.3% | -$0.21-40.0% | -$0.15— | ||
| -$0.130.0% | -$0.13+7.1% | -$0.14+33.3% | -$0.21-40.0% | -$0.15— | ||
| 60M+25.2% | 47.9M-5.4% | 50.7M+13.7% | 44.6M+2.6% | 43.4M+133% | ||
| 60M+25.2% | 47.9M-5.4% | 50.7M+13.7% | 44.6M+2.6% | 43.4M+133% | ||
| —— | $28.39K0.0% | $28.39K0.0% | $28.39K0.0% | $28.39K— | ||
| —— | $0-100% | $138.3K-57.1% | $322.66K+27.8% | $252.55K+1,653% | ||
| —— | $46.25K0.0% | $46.25K0.0% | $46.25K0.0% | $46.25K— | ||
| $452.01K— | $0+100% | -$6.21M-435% | $1.86M+317% | $445.54K-81.5% | ||
| $21.28K+3,393% | $609-90.0% | $6.06K-79.4% | $29.47K-70.6% | $100.1K-39.0% | ||
| $7.14M+9.7% | $6.51M+23.4% | $5.27M-39.4% | $8.7M+1,688% | -$547.88K-123% | ||
| -$48.85K-75.4% | -$27.85K— | $0+100% | -$156.46K+86.4% | -$1.15M-39.8% | ||
| -$4.41M+20.6% | -$5.56M+49.9% | -$11.09M-77.4% | -$6.25M-31.9% | -$4.74M-82.3% | ||
| —— | —— | $185.02K— | —— | —— | ||
| -$6.7K-100% | $1.41M+479% | -$372.85K-206% | $352.12K-0.2% | $352.65K+217% | ||
| $2.09K0.0% | $2.09K0.0% | $2.09K0.0% | $2.09K0.0% | $2.09K— | ||
| $2.8M+30.2% | $2.15M+48.6% | $1.45M+2.7% | $1.41M-1.2% | $1.42M+32.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is TuHURA Biosciences, Inc. profitable?
- TuHURA Biosciences, Inc. is not currently profitable: it reported a net loss of $30.9M over the trailing twelve months.
- What is TuHURA Biosciences, Inc.'s earnings per share?
- TuHURA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-0.61.
- Where does TuHURA Biosciences, Inc.'s income statement data come from?
- Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.